Procter & Gamble Hygiene and Health Care Limited has informed the Exchange about General Updates
PGHH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
P&G Hygiene and Health Care has re-submitted its unaudited Q1 FY26 results (quarter ended June 30, 2025) to the exchanges, as the original July 30 filing was not in a machine-readable format. Revenue from operations stood at ₹93,703 lakhs, marginally up from ₹93,175 lakhs in the corresponding quarter last year. Profit after tax jumped sharply to ₹19,206 lakhs from ₹7,967 lakhs, a growth of about 141%, driving EPS to ₹59.17 versus ₹24.97. The strong bottom-line growth came despite near-flat revenue, mainly because advertising and sales promotion expenses fell sharply to ₹6,873 lakhs from ₹15,366 lakhs in the year-ago quarter. The statutory auditor (Kalyaniwalla & Mistry LLP) issued an unqualified limited review report with no qualifications or emphasis of matter.
Sharply higher profitability and EPS, driven largely by a big drop in ad spends rather than topline growth, is a positive for shareholders in the near term but raises questions about whether lower marketing investment can sustain volumes. The clean auditor report and technical re-filing (no change in numbers) suggest no governance red flags.